Kura Oncology Balance Sheet Analysis

Assets, liabilities, and stockholders equity in billions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Kura Oncology, Inc. (KURA) - Annual data in billions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Current Assets
Cash and Cash Equivalents0.220.040.050.520.630.240.18
Short-Term Investments0.500.390.390.430.310.000.00
Cash & Short-Term Investments0.730.420.440.520.630.240.18
Accounts Receivable0.000.000.000.000.000.000.00
Inventory0.000.000.000.000.000.000.00
Other Current Assets0.020.010.010.000.000.000.00
Total Current Assets0.740.430.450.520.640.240.18
Non-Current Assets
Property, Plant & Equipment (Net)0.010.010.010.010.010.000.00
Other Non-Current Assets0.010.010.000.000.000.000.00
Total Non-Current Assets0.020.020.010.010.010.000.00
Total Assets0.760.450.460.530.650.240.18
Current Liabilities
Accounts Payable0.000.000.000.020.020.020.01
Short-Term Debt0.000.000.000.000.000.000.00
Current Portion of Long-Term Debt0.000.000.000.000.000.000.00
Accrued Liabilities0.050.030.010.020.020.000.00
Deferred Revenue0.020.000.000.000.000.000.00
Other Current Liabilities0.050.010.010.010.010.000.00
Total Current Liabilities0.080.040.020.020.030.020.01
Non-Current Liabilities
Long-Term Debt0.010.010.010.000.010.010.01
Other Non-Current Liabilities0.000.000.000.000.000.000.00
Total Non-Current Liabilities0.270.020.010.000.010.010.01
Total Liabilities0.350.050.040.030.040.020.02
Stockholders' Equity
Common Stock0.000.000.000.000.000.000.00
Retained Earnings-0.90-0.72-0.57-0.43-0.30-0.21-0.15
Accumulated Other Comprehensive Income0.000.00-0.010.000.000.000.00
Additional Paid-in Capital1.311.121.000.940.910.430.31
Shares Outstanding0.080.070.070.070.000.000.00
Total Stockholders' Equity0.410.400.420.510.610.220.16
Total Liabilities & Equity0.760.450.460.530.650.240.18